CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Can Cardiometabolic Syndrome Reshapes Digital Tech Solution?

How Can Cardiometabolic Syndrome...

Superbugs: How You Can Defend Superbugs with the Help of Biotechnology Firms?

Superbugs: How You Can Defend...

Aria Pharmaceutical's Implemented AI for Generating New Innovative Insights

Aria Pharmaceutical's Implemented AI...

Data Science In R&D: It Is About Culture

Data Science In R&D: It Is About Culture

Three Steps To Succeed With Digital Transformation In Pharma?

Three Steps To Succeed With Digital...

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Partnering With A Cdmo For Successful...

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Leading Global Cdmo, Pci Has Further...

Encouraging Innovation in Healthcare in a COVID - 19 World

Encouraging Innovation in Healthcare...

How Can Cardiometabolic Syndrome Reshapes Digital Tech Solution?

How Can Cardiometabolic Syndrome...

Superbugs: How You Can Defend Superbugs with the Help of Biotechnology Firms?

Superbugs: How You Can Defend...

Aria Pharmaceutical's Implemented AI for Generating New Innovative Insights

Aria Pharmaceutical's Implemented AI...

Data Science In R&D: It Is About Culture

Data Science In R&D: It Is About Culture

Three Steps To Succeed With Digital Transformation In Pharma?

Three Steps To Succeed With Digital...

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Partnering With A Cdmo For Successful...

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Leading Global Cdmo, Pci Has Further...

Encouraging Innovation in Healthcare in a COVID - 19 World

Encouraging Innovation in Healthcare...

Most Common Antibiotic-Resistant Infections Caused by Bacteria

Life Sciences Review | Tuesday, March 01, 2022
Tweet

CRE is a bacterial family that is commonly found in our stomachs, but some of these bacteria can cause life-threatening blood infections and are antibiotic-resistant


Fremont, CA: Superbugs are viruses, parasites, bacteria, and fungi strains that are resistant to most antibiotics and other medications utilized to treat the infections they cause. Antibiotics have been used to treat bacteria that have adapted and changed in order to develop resistance. Superbugs are antibiotic-resistant bacteria that can cause severe bacterial infections that are extremely difficult to treat.


Common Antibiotic-Resistant Superbugs to Know About:


Multidrug-Resistant Acinetobacter: This bacteria's superbug strain, Acinetobacter baumannii, can be found in water, soil, and the skin. It develops antibiotic resistance faster than other bacteria and is most common in hospitals.


Neisseria gonorrhoeae: This strain of bacteria causes gonorrhea, an STD that was previously easily treated with antibiotics. Neisseria gonorrhoeae, on the other hand, is becoming increasingly resistant to them.


Carbapenem-Resistant Enterobacteriaceae (CRE): CRE is a bacterial family that is commonly found in our stomachs, but some of these bacteria can cause life-threatening blood infections and are antibiotic-resistant.


MRSA: MRSA (methicillin-resistant Staphylococcus aureus) Staphylococcus aureus is a difficult staph infection to treat. Although MRSA is antibiotic-resistant, it still responds to some antibiotics, and the frequency of life-threatening MRSA has decreased.


Clostridium difficile (C.diff): C. diff is a bacteria that lives in your intestines and can cause severe diarrhea if it grows too large. It can be passed from person to person via spores in bathrooms and on clothing, and it is not always treatable with antibiotics. C. diff can be fatal if not treated.


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis
Data Science In R&D: It Is About Culture

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore, at Lonza
Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Chris Dobbs, CEng., MIET, Head of Technical Engineering, PCI Pharma Services
Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Encouraging Innovation in Healthcare in a COVID - 19 World

Duncan Turner, General Partner, SOSV, Managing Director, HAX
Encouraging Innovation in Healthcare in a COVID - 19 World
How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

Gil Carrasquinho, VP Head of Cell Therapy, Santen
Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Craig Herron, Managing Director, iSelect Fund

Addressing the Expanded Role of Patient Engagement in Clinical Research

Denis Curtin, PhD, Principal, eCOA & Patient Engagement, Signant Health
Addressing the Expanded Role of Patient Engagement in Clinical Research

The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery

Jason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZeneca
The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/most-common-antibioticresistant-infections-caused-by-bacteria-nwid-734.html